The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2013. The increased amount of exits for fund were in 2014. Deals in the range of 100 thousands - 1 million dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 1 partaker.
Among the most successful fund investment fields, there are Industrial, iOS. Among the most popular portfolio startups of the fund, we may highlight PLx Pharma.
Related Funds
| Fund Name | Location |
| 1Crowd | India, Maharashtra, Mumbai |
| Cavendish Capital | - |
| Cenova Capital | - |
| GC Investments | Golejow, Poland, Slaskie |
| Haerbin Dongfang Huifu Chuangtou | China, Harbin, Heilongjiang |
| Linamar | Canada, Guelph, Ontario |
| Maher Capital | Seattle, United States, Washington |
| MarsBio | California, Los Angeles, United States |
| Matrix Investment Holdings, LLC | - |
| MPGI | England, London, United Kingdom |
| PM Equity Partner | Lausanne, Switzerland, Vaud |
| Sankonline | Istanbul, Istanbul, Turkey |
| Shanghai Ouqing Equity Investment Management | China, Shanghai |
| Straight Shot | Nebraska, Omaha, United States |
| Swiss Federal Commission for Innovation and Technology | Bern, Bern, Switzerland |
| Techammer | New York, New York, United States |
| Yihua Enterprise (Group) | China, Guangdong, Shantou |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 